Download PDF
Thromb Haemost 1993; 70(01): 063-067
DOI: 10.1055/s-0038-1646161
State-of-the-Art Lecture
Hemophilia
Schattauer GmbH Stuttgart

Factor VIII Structure and Function

Philip J Fay
Department of Medicine, University of Rochester School of Medicine & Dentistry, Rochester, New York, USA
› Author Affiliations
Further Information

Publication History

Publication Date:
03 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. J Clin Invest 1977; 60: 390-404
    CrossrefPubMedGoogle Scholar
  • 2 Kaufman RJ, Wasley LC, Dorner AJ. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 1988; 263: 6352-6362
    PubMedGoogle Scholar
  • 3 Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. 1990; Blood 76: 1-16
    PubMedGoogle Scholar
  • 4 van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIIIa in the activation of bovine factor Xa. J Biol Chem 1981; 256: 3433-3442
    PubMedGoogle Scholar
  • 5 Mutucumarana VP, Duffy EJ, Lollar P, Johnson AE. The active site of factor IXa is located far above the membrane surface and its conformation is altered upon association with factor Villa. J Biol Chem 1992; 267: 17012-17021
    PubMedGoogle Scholar
  • 6 Wood WI, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, Seeburg PH, Smith DH, Hollingshead P, Wion KL. Expression of active human factor VIII from recombinant DNA clones. Nature 1984; 312: 330-337
    CrossrefPubMedGoogle Scholar
  • 7 Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Beucker JL, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 1984; 312: 342-347
    CrossrefPubMedGoogle Scholar
  • 8 Vehar GA, Keyt B, Eaton D, Rodriguez H, O'Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RN. Structure of human factor VIII. Nature 1984; 312: 337-342
    CrossrefPubMedGoogle Scholar
  • 9 Vehar G, Davie EW. Preparation and properties of bovine factor VIII. Biochemistry 1980; 19: 401-410
    CrossrefPubMedGoogle Scholar
  • 10 Fass DN, Knutson GJ, Katzmann JA. Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein. Blood 1982; 59: 594-600
    PubMedGoogle Scholar
  • 11 Fulcher CA, Zimmerman TS. Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody. Proc Natl Acad Sci USA 1982; 79: 1648-1652
    CrossrefPubMedGoogle Scholar
  • 12 Rotblat F, O'Brien DP, O'Brien FJ, Goodall AH, Tuddenham EG. Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies. Biochemistry 1985; 24: 4294-4300
    CrossrefPubMedGoogle Scholar
  • 13 Andersson LO, Forsman N, Huang K, Larsen K, Lundin A, Pavlu B, Sandberg H, Sewerin K, Smart J. Isolation and characterization of human factor VIII: Molecular forms in commercial factor VIII concentration, cryoprecipitate, and plasma. Proc Natl Acad Sci USA 1986; 83: 2979-2983
    CrossrefPubMedGoogle Scholar
  • 14 Fay PJ, Anderson MT, Chavin SI, and Marder VJ. The heterodimeric structure of human factor VIII and changes produced by thrombin interaction. Biochim Biophys Acta 1986; 871: 268-278
    CrossrefPubMedGoogle Scholar
  • 15 Eaton D, Rodriguez H, Vehar G. Proteolytic processing of human factor VIII: Correlation of specific cleavage by thrombin, factor Xa and activation protein C with activity and inactivation of factor VIII coagulant activity. Biochemistry 1986; 25: 505-512
    CrossrefPubMedGoogle Scholar
  • 16 Hamer RJ, Koedam JA, Beeser-Visser NH, Sixma JJ. Human factor VIII: Purification from commercial factor VIII concentration, characterization, identification and radiolabeling. Biochim Biophys Acta 1986; 873: 356-366
    CrossrefPubMedGoogle Scholar
  • 17 Fay PJ, Smudzin TM. Characterization of the interaction between the A2 subunit and A1/A3-C1-C2 dimer in human factor Villa. J Biol Chem 1992; 267: 13246-13250
    PubMedGoogle Scholar
  • 18 Esmon CT. The subunit structure of thrombin activated factor V. J Biol Chem 1979; 254: 964-973
    PubMedGoogle Scholar
  • 19 Fay PJ. Reconstitution of human factor VIII from isolated subunits. Arch Biochem Biophys 1988; 262: 525-531
    CrossrefPubMedGoogle Scholar
  • 20 Nordfang O, Ezban M. Generation of active coagulation factor VIII from isolated subunits. J Biol Chem 1988; 263: 1115-1118
    PubMedGoogle Scholar
  • 21 Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc Natl Acad Sci USA, 1986; 83: 5939-5942
    CrossrefPubMedGoogle Scholar
  • 22 Eaton DL, Wood WI, Eaton D, Hass PE, Hollingshead P, Wion K, Mather J, Lawn RM, Vehar GA, Gorman C. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 1986; 25: 8343-8347
    CrossrefPubMedGoogle Scholar
  • 23 Mosesson MW, Fass DN, Lollar P, DiOrio JP, Parker CG, Knutson GJ, Hainfeld JF, Wall JS. Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis. J Clin Invest 1990; 85: 1983-1990
    CrossrefPubMedGoogle Scholar
  • 24 Fowler WE, Fay PJ, Arvan D, and Marder VJ. Electron microscopy of human factor V and factor VIII: Correlation of morphology with domain structure and localization of factor V activation fragments. Proc Natl Acad Sci USA 1990; 87: 7648-7652
    CrossrefPubMedGoogle Scholar
  • 25 Fay PJ, Smudzin TM. Inter-subunit fluorescence energy transfer in human factor VIII. J Biol Chem 1989; 264: 14005-14010
    PubMedGoogle Scholar
  • 26 Owen WG, Wagner RH. Anti-hemophilic factor: Separation of an active fragment following dissociation by salts or detergents. Thromb Diath Haemorrh 1982; 27: 502-515
    PubMedGoogle Scholar
  • 27 Lollar P, Parker CG. Stoichiometry of the porcine factor VIII-von Willebrand factor association. J Biol Chem 1987; 262: 17572-17576
    PubMedGoogle Scholar
  • 28 Andersson LO, Brown JE. Interaction of factor VIII-von Willebrand factor with phospholipid vesicles. Biochem J 1981; 100: 161-167
    PubMedGoogle Scholar
  • 29 Nesheim M, Pittman DD, Giles AR, Fass DN, Wang JH, Slonosky D, Kaufman RJ. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets. J Biol Chem 1991; 166: 17815-17820
    PubMedGoogle Scholar
  • 30 Hamer RJ, Koedam JA, Beeser-Visser NH, Bertina RM, vanMourik JA, Sixma JJ. Factor VIII binds to von Willebrand factor via its Mr~80,000 light chain. Eur J Biochem 1987; 166: 37-43
    CrossrefPubMedGoogle Scholar
  • 31 Bloom JW. The interaction of rDNA factor VIII, factor VIIIdes797-1562 and factor VIIIdeS797-1562-derived peptides with phospholipid. Thromb Res 48: 439-448 1987;
    CrossrefPubMedGoogle Scholar
  • 32 Foster PA, Fulcher CA, Houghten RA, Zimmerman TS. An immunogenic region with residues Val1670-Glu1684 of factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 1988; 263: 5230-5234
    PubMedGoogle Scholar
  • 33 Leyte A, van Schijndel HB, Niehrs C, Huttner WB, Verbeet MP, Mertens K, vanMourik JA. Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor. J Biol Chem 1990; 266: 740-746
    PubMedGoogle Scholar
  • 34 Foster PA, Fulcher CA, Houghten RA, Zimmerman TS. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phos-phatidylserine. Blood 1990; 75: 1999-2004
    PubMedGoogle Scholar
  • 35 Leyte A, Verbeet MP, Brodniewicz-Probe T, vanMourik JA, Mertens K. The interaction between human blood coagulation factor VIII and von Willebrand factor: Characterization of a high affinity binding site on factor VIII. Biochem J 1989; 157: 679-683
    PubMedGoogle Scholar
  • 36 Gilbert GE, Furie BC, Furie B. Binding of human factor VIII to phospholipid vesicles. J Biol Chem 1990; 265: 815-822
    PubMedGoogle Scholar
  • 37 Lollar P, Knutson GJ, Fass DN. Activation of porcine factor VIII:C by thrombin and factor Xa. Biochemistry 1985; 24: 6056-6064
    PubMedGoogle Scholar
  • 38 Pieters J, Lindhout T, Hemker HC. In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastin-activated plasma. Blood 1989; 74: 1021-1024
    PubMedGoogle Scholar
  • 39 Koedam JA, Hamer RJ, Besser-Visser NH, Bouma BN, Sixma JJ. The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 1990; 1898: 229-234
    PubMedGoogle Scholar
  • 40 Bihoreau N, Sauger A, Yon JM, van de Pol H. Isolation and characterization of different activated forms of factor VIII. Eur J Biochem 1989; 185: 111-118
    CrossrefPubMedGoogle Scholar
  • 41 Hill-Eubanks DC, Parker CG, Lollar P. Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin. Proc Natl Acad Sci USA 1989; 86: 6508-6512
    CrossrefPubMedGoogle Scholar
  • 42 Hill-Eubanks DC, Lollar P. von Willebrand factor is a cofactor for thrombin-catalyzed cleavage of the factor VIII light chain. J Biol Chem 1990; 265: 17854-17858
    PubMedGoogle Scholar
  • 43 Pittman DD, Kaufman RJ. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proc Natl Acad Sci USA 1988; 85: 2429-2433
    CrossrefPubMedGoogle Scholar
  • 44 Lollar P, Parker CG. Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 1989; 28: 666-674
    CrossrefPubMedGoogle Scholar
  • 45 Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure: Reconstitution of factor Villa from the isolated A1/A3-C1-C2 dimer and A2 subunit. J Biol Chem 1991; 266: 8957-8962
    PubMedGoogle Scholar
  • 46 Lollar P, Parker CG. pH-dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem 1990; 265: 1688-1692
    PubMedGoogle Scholar
  • 47 Lamphear BJ, Fay PJ. Factor IXa enhances reconstitution of factor VIIIa from isolated A2 subunit and A1/A3-C1-C2 dimer. J Biol Chem 1992; 267: 3725-3730
    PubMedGoogle Scholar
  • 48 Hultin MB, Jesty J. Activation and inactivation of human factor VIII by thrombin: Effects of inhibitors of thrombin. Blood 1981; 57: 476-482
    PubMedGoogle Scholar
  • 49 Rick ME, Hoyer LW. Thrombin activation of factor VIII: Effects of inhibitors. Br J Haematol 1977; 36: 585-597
    CrossrefPubMedGoogle Scholar
  • 50 Lollar P, Parker ET, Fay PJ. Coagulant properties of hybrid human/porcine factor VIII molecules. J Biol Chem 1992; 267: 23652-23657
    PubMedGoogle Scholar
  • 51 Duffy EJ, Parker ET, Mutucumarana VP, Johnson AE, Lollar P. Binding of factor VIIa and factor VIII to factor IXa on phospholipid vesicles. J Biol Chem 1992; 267: 17006-17011
    PubMedGoogle Scholar
  • 52 Lollar P, Knutson GJ, Fass DN. Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. Blood 1984; 63: 1303-1308
    PubMedGoogle Scholar
  • 53 Lollar P, Fass DN. Inhibition of activated porcine factor IX by dan-syl-glutamyl-glycyl-arginyl-chloromethylketone. Arch Biochem Bio-phys 1984; 233: 438-446
    CrossrefPubMedGoogle Scholar
  • 54 O'Brien DP, Johnson D, Byfield P, Tuddenham EG. Inactivation of factor VIII by factor IXa. Biochemistry 1992; 31: 2805-1812
    CrossrefPubMedGoogle Scholar
  • 55 Lamphear BJ, Fay PJ. Proteolytic interactions of factor IXa with human factor VIII and factor VIIa. Blood 1992; 80: 3120-3126
    PubMedGoogle Scholar
  • 56 Walker FJ, Fay PJ. Regulation of blood cogulation by the protein C system. FASEB J 1992; 6: 2562-2567
    PubMedGoogle Scholar
  • 57 Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated protein C and its analogy with factor V. Blood 1984; 63: 486-489
    PubMedGoogle Scholar
  • 58 Walker FJ, Chavin SI, Fay PJ. Inactivation of factor VIII by activated protein C and protein S. Arch Biochem Biophys 1987; 252: 322-328
    CrossrefPubMedGoogle Scholar
  • 59 Fay PJ, Smudzin TM, Walker FJ. Activated protein C catalyzed inactivation of human factor VIII and factor VIIIa: Identification of cleavage sites and correlation of proteolysis with cofactor activity. J Biol Chem 1991; 266: 20139-20145
    PubMedGoogle Scholar
  • 60 Odegaard B, Mann KG. Proteolysis of factor Va by factor Xa and activated protein C. J Biol Chem 1987; 262: 11233-11238
    PubMedGoogle Scholar
  • 61 Guinto ER, Esmon CT. Loss of prothrombin and factor Xa-factor Va interaction upon inactivation of factor Va by activated protein C. J Biol Chem 1984; 259: 13986-13992
    PubMedGoogle Scholar
  • 62 Aly AM, Higuchi M, Kasper CK, Kazazian HH, Antonarakis SE, Hoyer LW. Hemophilia A due to mutations that create new N-glyco-sylation sites. Proc Natl Acad Sci USA 1992; 89: 4933-4937
    CrossrefPubMedGoogle Scholar
  • 63 Suzuki K, Stenflo J, Dahlback B, Theodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983; 258: 1914-1920
    PubMedGoogle Scholar
  • 64 Fay PJ, Walker FJ. Inactivation of human factor VIII by activated protein C: Evidence that the factor VIII light chain contains the activated protein C binding site. Biochim Biophys Acta 1989; 994: 142-148
    CrossrefPubMedGoogle Scholar
  • 65 Krishnaswamy S, Williams EB, Mann KG. The binding of activated protein C to factor V and Va. J Biol Chem 1986; 261: 9684-9693
    PubMedGoogle Scholar
  • 66 Walker FJ, Scandella D, Fay PJ. Identification of the binding site for activated protein C on the light chain of factor V and factor VIII. J Biol Chem 1990; 265: 1484-1489
    PubMedGoogle Scholar
  • 67 Koedam JA, Meijers JCM, Sixma JJ, Bouma B. Inactivation of factor VIII by activated protein C: Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 1988; 82: 1236-1243
    CrossrefPubMedGoogle Scholar
  • 68 Fay PJ, Coumans JV, Walker FJ. von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem 1991; 266: 2172-2177
    PubMedGoogle Scholar
  • 69 Walker JF, Sexton PW, Esmon CT. The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V. Biochim Biophys Acta 1979; 571: 333-342
    CrossrefPubMedGoogle Scholar
  • 70 Nesheim ME, Canfield WM, Kisiel W, Mann KG. Studies of the capacity of factor X to protect factor Va from inactivation by activated protein C. J Biol Chem 1982; 257: 1443-1447
    PubMedGoogle Scholar
  • 71 Solymoss S, Tucker MM, Tracy PB. Kinetics of inactivation of membrane-bound factor Va by activated protein C. J Biol Chem 1988; 263: 14884-14890
    PubMedGoogle Scholar
  • 72 Bertina RM, Cupers R, van Wijngaardon A. Factor IXa protects activated factor VIII against inactivation by activated protein C. Biochem Biophys Res Commun 1984; 125: 177-183
    CrossrefPubMedGoogle Scholar
  • 73 Rick ME, Esmon NL, Krizek DM. Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C. J Lab Clin Med 1990; 115: 415-421
    PubMedGoogle Scholar